Prana raises US$3.7 million
Wednesday, 08 December, 2004
A number of US institutional investors have purchased and exercised 9.5 million options in Prana Biotechnology (NASDAQ: PRAN, ASX: PBT) at $0.50 per share, raising US$3.7 million for the company.
The options - originally owned by directors and insiders of Prana - were exercised prior to their scheduled expiry date of December 1, 2004.
The exercise of options increases the total issued shares in Prana to 126,890,821.
ADHD may be linked with an increased risk of dementia
An adult brain affected by attention deficit hyperactivity disorder (ADHD) presents modifications...
Placebos appear to reduce PMS symptoms
Women affected by premenstrual syndrome (PMS) appear to experience less intense and debilitating...
Medicinal cannabis linked to long-term health benefits
As scientists find a way to improve the effectiveness of CBD, a separate study shows that...
